234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
Nov 10, 2022
32:56
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.
The Readout Loud